biotech · Major Depressive Disorder · Schizophrenia · NBIX
NEUROCRINE BIOSCIENCES
NEUROCRINE BIOSCIENCES INC
NEUROCRINE BIOSCIENCES patent portfolio — 111 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- 6027 Edgewood Bend Ct, San Diego, California 92130, US
- Founded
- 1992
- Employees
- 2,307
- Programs
- 79
- Drugs
- 28
- Patents
- 111
NEUROCRINE BIOSCIENCES patents
111 pharmaceutical patents indexed for NEUROCRINE BIOSCIENCES. 8 expire within 24 months.
NEUROCRINE BIOSCIENCES has 111 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 8 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 6485746
Controlled-release sedative-hypnotic compositions and methods related thereto
expired -
US 6469166
Thiophenopyrimidines
expired -
US 6440960
CRF receptor antagonists and methods relating thereto
expired -
US 6384221
Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-&agr;]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
expired -
US 6379670
Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
expired -
US 6369033
Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein
expired -
US 6348466
CRF receptor antagonists and methods relating thereto
expired -
US 6329499
Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein
expired -
US 6288060
Amino substituted pyrimidines and triazines
expired -
US 6255310
Thiophenopyrimidines
expired -
US 6251396
Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
expired -
US 6239268
Interleukin-1 type 3 receptors
expired -
US 6211195
CRF antagonistic thiophenopyridines
expired -
US 6197926
Methods for treatment of diabetes using peptide analogues of insulin
expired -
US 6133276
Compounds and methods for increasing endogenous levels of corticotropin-releasing factor
expired
Frequently asked questions
How many patents does NEUROCRINE BIOSCIENCES have?
111 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do NEUROCRINE BIOSCIENCES patents expire?
8 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.